📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The PI3K p110d Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function (2019)

First Author: Chellappa S

Attributed to: Immune responses to the environment funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.4049/jimmunol.1701703

PubMed Identifier: 30692213

Publication URI: http://europepmc.org/abstract/MED/30692213

Type: Journal Article/Review

Parent Publication: The Journal of Immunology

Issue: 5

ISSN: 0022-1767